Home > Boards > US OTC > Medical - Drugs > Creative Medical Technology Holdings Inc. (CELZ)

The key players of stem cell exosome therapeutic

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
uplinkjim Member Profile
 
Followed By 6
Posts 489
Boards Moderated 0
Alias Born 10/26/09
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 2/22/2021 4:06:17 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 2/22/2021 9:15:52 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/18/2021 4:06:13 PM
Creative Medical files for new immcelz patent Seeking Alpha - 2/16/2021 7:55:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/12/2021 10:29:29 AM
Therapeutic Solutions stock rises after JadiCell deal Seeking Alpha - 2/10/2021 9:32:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/8/2021 4:31:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/14/2021 8:01:18 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/8/2021 4:46:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/8/2021 4:45:56 PM
Epazz, Inc. (OTC Pink: EPAZ) Emerging in Blockchain and Cryptocurrency InvestorsHub NewsWire - 1/6/2021 6:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/4/2021 4:06:24 PM
4 OTC Stocks on the Move: CELZ DSGT IQST PMPG InvestorsHub NewsWire - 1/4/2021 9:23:20 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/31/2020 4:31:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/31/2020 4:31:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/31/2020 4:30:40 PM
IQST Blue Sky Breakout Mode - The Run On IQST InvestorsHub NewsWire - 12/31/2020 9:03:09 AM
IQST Up 100% To $0.14 On Steady Climb - Analyst Recommended $0.54 Target InvestorsHub NewsWire - 12/30/2020 12:54:24 PM
Epazz, Inc. (OTC Pink: EPAZ) Tapping Blockchain & Cryptocurrency with IEO InvestorsHub NewsWire - 12/30/2020 6:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/13/2020 4:46:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/2/2020 4:43:19 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/14/2020 4:32:40 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/5/2020 4:06:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/5/2020 4:06:19 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2020 4:36:39 PM
uplinkjim   Sunday, 10/20/19 09:11:25 AM
Re: None
Post # of 109006 
The key players of stem cell exosome therapeutic market include Evox Therapeutics, Capricor Therapeutics, Inc., Unicyte AG, Exogenus Therapeutics, Everkine Corporation, Creative Medical Technology Holdings Anjarium Biosciences, Kimera Labs, ReNeuron, Stem Cell Medicine Ltd., and Codiak Biosciences

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences